PARIS (Reuters) - Sanofi said on Monday that a large clinical trial showed its Fluzone High-Dose vaccine to be more effective at preventing influenza in adults aged 65 and older than a standard dose of Fluzone.
via Reuters: Health News Read More Here..
No comments:
Post a Comment